Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
James Hippel is CFO at Bio-Techne. OQRO lists 21 transactions filed with the SEC under this name, the latest on Nov 3, 2026, each linked to the official Form 4.
CFO
Disclosures on record
21
Companies involved
1
James Hippel has no open-market purchase on record since 2019. Sales in 3 of the 8 years since 2019.
James Hippel reported 0 open-market purchases and 77 sales since 2019; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2021 | — | $31.1M44×44 trades |
| 2020 | — | $14.4M29×29 trades |
| 2019 | — | $14.7M4×4 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Bio-TechneTECH
21 disclosures · Apr 2026 – Nov 2026
Nov 1, 202612Kdisclosed Nov 3
DetailsOfficial recordNov 1, 202612Kdisclosed Nov 3
DetailsOfficial recordNov 1, 20265,096disclosed Nov 3
DetailsOfficial recordAug 15, 20264,903disclosed Nov 2
DetailsOfficial recordAug 15, 20269,980disclosed Nov 2
DetailsOfficial recordAug 15, 20261,067disclosed Nov 2
DetailsOfficial recordAug 15, 20264,010disclosed Nov 2
DetailsOfficial recordAug 15, 202613Kdisclosed Nov 2
DetailsOfficial recordAug 15, 202634Kdisclosed Nov 2
DetailsOfficial recordAug 15, 20264,423disclosed Nov 2
DetailsOfficial recordAug 17, 202622Kdisclosed Aug 19
DetailsOfficial recordAug 17, 202636Kdisclosed Aug 19
DetailsOfficial recordJul 29, 202662Kdisclosed Jul 31
DetailsOfficial recordJul 29, 202662Kdisclosed Jul 31
DetailsOfficial recordJul 29, 202651Kdisclosed Jul 31
DetailsOfficial recordMay 5, 202662Kdisclosed May 7
DetailsOfficial recordMay 5, 202662Kdisclosed May 7
DetailsOfficial recordMay 5, 202657Kdisclosed May 7
DetailsOfficial recordApr 22, 202662Kdisclosed Apr 24
DetailsOfficial recordApr 22, 202662Kdisclosed Apr 24
DetailsOfficial recordApr 22, 202656Kdisclosed Apr 24
DetailsOfficial recordAs of the latest filing on , James Hippel reported holding 176,720 shares of Bio-Techne (TECH), worth about $12.9M at the last close of $73 (Nov 18, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Bio-Techne TECH | 176,720 | 177K direct | $73 | $12.9M | Nov 1, 2026 |
Is this James Hippel’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
James Hippel reported 0 open-market purchases and 77 sales here, 2019 to 2021.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
On the latest SEC Form 4, dated Nov 1, 2026, James Hippel reported holding 176,720 shares of Bio-Techne (TECH). At the last close of $73 on Nov 18, 2026, that is about $12.9M. This is the stake disclosed in filings, not a net worth.
No public filing gives James Hippel's net worth. What SEC Form 4 shows is the stock stake: 176,720 shares of Bio-Techne (TECH), about $12.9M at the last close. Cash, other investments, property, debts and unexercised options are not in these filings, so the real figure can be much higher or lower.
James Hippel has no open-market purchase on record since 2019. Sales in 3 of the 8 years since 2019.
In SEC filings since 2019: no open-market purchase is on record; the latest open-market sale is from 2021.
Bio-Techne (TECH), from 2019 to 2021: 0 purchases and 77 sales.